ALFA FinderNSE filing, NSE: QLINE. Summary written from the filing by ALFA Finder's alert engine.
Q-Line Biotech Ltd: key numbers
- Share price
- ₹557.00
- Market cap
- ₹1,299 Cr
- Revenue (annual)
- ₹341.7 Cr
- Net profit (annual)
- ₹55.72 Cr
- P/E (TTM)
- 23.3×Sector 54.5×
- Promoter holding
- 67.51%
- FII holding
- 0.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Q-Line Biotech Ltd
All →Q-Line Biotech Other Announcement
Q-Line Biotech filed its IPO monitoring agency report for the half year to September 2026. It flags Rs. 0.97 crore of prepayment charges paid from issue proceeds.
Q-Line Biotech H1 FY27 Results: Net Profit ₹19.6 Cr, Down 8.0% YoY
Q-Line Biotech Ltd reported revenue from operations of ₹152.2 Cr (+5.8% YoY) and net profit of ₹19.6 Cr (-8.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹19.6 Cr · -8.0% YoY
Q-Line Biotech Legal & Regulatory
Q-Line Biotech's board said a Rs.10,000 NSE fine for late XBRL voting-results filing was due to a portal glitch and requested a waiver. The total payable including GST is Rs.11,800.
- Value
- ₹0.01 Cr
Q-Line Biotech Board Meeting Date
Q-Line Biotech clarified a clerical error: its board meeting time is 4:15 PM, not 3:00 PM. The November 12, 2026 meeting will consider half-yearly financial results.
Q-Line Biotech Annual General Meeting
Q-Line Biotech Limited held its 16th Annual General Meeting on September 30, 2026. The meeting transacted ordinary and special business, including financial statement adoption and director re-appointments.
Q-Line Biotech Annual General Meeting
Q-Line Biotech has sent a letter to shareholders with bounced emails, providing links to the Annual Report and 16th AGM Notice, scheduled for September 30, 2026.
Other results update announcements
All →Gaudium IVF And Women Health Results Update
Gaudium IVF reported Q2 FY27 revenue of ₹37.4 crore, up 17.9% YoY, with H1 revenue at ₹56.8 crore. Two new IVF hubs commenced operations during the quarter.
Systematix Corporate Services Results Update
Systematix's Q2 FY27 adjusted revenue rose 102% QoQ to ₹56.04 crore, with PAT of ₹13.13 crore. Year-on-year revenue was flat, while H1 PAT fell to ₹8.24 crore.
TARC Results Update
TARC reported H1 FY2027 total income of ₹352.78 crore and PAT of ₹27 crore. Q2 PAT was ₹4.05 crore, versus a loss in Q2 FY2026.
Balaxi Pharmaceuticals Results Update
Balaxi Pharmaceuticals issued a press release on Q2 FY27 results, with revenue up 45% and PAT up 450% year-on-year. EBITDA rose 338% to ₹512.07 lakh.
Piccadily Agro Industries Results Update
Piccadily Agro reported Q2 FY27 revenue of ₹277.9 crore, up 19.4% YoY. Distillery business revenue increased 30.5% YoY to ₹271.3 crore.
- Value
- ₹277.9 Cr
- maturation capacity
- 96000.0 barrels
Markolines Pavement Technologies Results Update
Markolines Pavement Technologies reported Q2 FY27 revenue of ₹86.02 crore (+10.75% YoY) and PAT of ₹4.95 crore (+21.21% YoY) in a press release. It also disclosed two BMC work orders aggregating ₹135.20 crore.